Regenxbio Inc (RGNX)
Healthcare
Biotechnology
9.70 $
-4.2%
vs. previous close
Closing price · As of: 31. Jul 2026
Regenxbio Inc (RGNX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -124 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.4 | -23 | -49 | -58 | 105 | -108 | -54 | 219 | -207 | -218 | -173 | -124 | |
| 0.1 | 0.1 | 0.5 | 2.7 | 4.0 | 7.2 | 8.4 | 9.6 | 13 | 17 | 16 | 16 | |
| 0.3 | 2.9 | 7.0 | 11 | 17 | 27 | 32 | 39 | 41 | 40 | 38 | 35 | |
| 0.5 | 3.3 | 8.6 | 12 | 17 | 21 | 41 | 41 | 46 | – | – | – | |
| 1.1 | -3.0 | 5.2 | 0.9 | -7.8 | -5.3 | 14 | 40 | 14 | -11 | 5.5 | 12 | |
| 0.5 | 0.5 | 8.1 | 7.2 | 13 | 12 | 27 | 84 | 31 | 10.0 | 2.4 | 2.4 | |
| -164 | -164 | 19 | -4.8 | -279 | 94 | 123 | -407 | -12 | 191 | 103 | -16 | |
| – | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| 0.0 | 239 | 0.2 | 0.6 | 0.8 | 1.3 | 1.8 | 0.0 | -0.3 | -0.4 | 1.2 | 1.0 | |
| 2.4 | – | – | – | – | – | – | – | – | – | 0.0 | 144 | |
| 2.4 | 239 | 0.1 | 85 | 204 | 8.4 | 200 | 195 | -29 | -35 | 93 | 117 | |
| 0.0 | 53 | -29 | 22 | 30 | -5.8 | 269 | 7.5 | -248 | -62 | 23 | -23 | |
| -2.4 | -23 | -57 | -65 | 91 | -119 | -81 | 135 | -238 | -228 | -176 | -126 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.